Immutep sinks 35pc despite revealing positive topline results for cancer-treatment trial. Investors may have had higher expectations. ...

Proteomics to start selling in France, Recce granted ethical approval for clinical trials, and EMV gets $1.25m grant. ...

Competitive: Syneos Health - USA: Principal Clinical Trial Manager - Ophthalmology Syneos Health® is a leading fully integrated biopharmaceutical...

Competitive: Syneos Health - USA: Principal Clinical Trial Manager - Ophthalmology Syneos Health® is a leading fully integrated biopharmaceutical...

While many Aussies turn to health professionals for mental health and stress, the ASX wellness sector is also looking to ...

U.S. stocks are drifting Monday after the French market rallied, as elections continue to drive swings in financial markets worldwide.

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from...

This week’s Bulls N’ Bears ASX Runner of the Week is … Schrole Group. Its shares jumped 187.5 per cent, while the new listing of Guzman y Gomez...

Control Bionics' shares surge after TGA approval, and Botanix Pharma granted US FDA approval for Sofdra (sofpironium) gel. ...